AI-generated summary
The authors describe implantable photonic devices, including an ingestible pill, that can deliver light-based treatments inside the body and transmit images to an external control box. In preliminary work they report red light illumination of the sinus-carotid zone in dogs was associated with changes in arterial pressure and heart rate, and describe blue light use during a maxillofacial treatment. The abstract presents these as early, preliminary clinical trial results.
- Who or what was studied
- Dogs for the sinus-carotid zone experiment; one patient case for maxillofacial phlegmon treatment, as described in preliminary clinical trials
- Wavelengths
- 450 nm
- Limits stated in the abstract
- The abstract describes the work as preliminary clinical trials and does not report sample sizes, controls, or outcome statistics.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on spiedigitallibrary.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 450 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Phototherapy, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.